Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021

NEXT STORY
InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis
PREV STORY
SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

United States Companion Animal Diagnostics Market Outlook and Forecast 2018-2023: Growing Demand for Automated Analyzers and Integration of Various Diagnostic Platforms

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy Company release August 16, 2018 at 04:15 PM EET FIT Biotech ...

author_avatar
NASDAQ Market News

Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891

author_avatar
NASDAQ Market News